Melinta receives positive CHMP opinion for Vabomere™ (meropenem and vaborbactam)
Melinta Therapeutics announced the CHMP of the EMA has adopted a positive opinion recommending Vabomere™ (meropenem and vaborbactam) for approval as treatment for adult patients with complicated intra-abdominal and urinary tract infections. September 21, 2018